Nature Communications · 2022 · 45 citations · 60 references
Life SciencesImmunologyPathologyHemostasisInflammationInnate ImmunityCytokine BiologyInflammatory Cell ResponsesInflammatory SignalingInnate Immune ActivationPlatelet ActivationPlatelet PhysiologyInflammation-associated ThrombosisInflammatory Cytokine ProfilesInnate Immune Cell FunctionInnate Immune CytokinesMonocyte PhysiologyPlatelet Aggregation DefectsPro-inflammatory Cytokine ExpressionThrombosis In Inflammation
monocytes in patients with mild and moderate COVID-19 during the acute phase of infection and in healthy individuals. Monocytes from COVID-19 patients display altered expression of cell surface receptors and a dysfunctional metabolic profile that distinguish them from healthy monocytes. Secondary pathogen sensing ex vivo leads to defects in pro-inflammatory cytokine and type-I IFN production in moderate COVID-19 cases, together with defects in glycolysis. COVID-19 monocytes switch their gene expression profile from canonical innate immune to pro-thrombotic signatures and are functionally pro-thrombotic, both at baseline and following ex vivo stimulation with SARS-CoV-2. Transcriptionally, COVID-19 monocytes are characterized by enrichment of pathways involved in hemostasis, immunothrombosis, platelet aggregation and other accessory pathways to platelet activation and clot formation. These results identify a potential mechanism by which monocyte dysfunction may contribute to COVID-19 pathology.
60
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin, Carrie Davis, Felix Schlesinger et al. · Bioinformatics · 2012 · 56.2K citations · Full text
NF-κB signaling in inflammation
Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 8.1K citations · Full text
Life Sciences, Immunology, Pathology +17